Contents - Neurology brit.jpg (17257 bytes)


Enzyme Therapy by Patients with Multiple Sclerosis (MU-89201)
Baumhackl U.

Wobenzym® and Wobe-Mugos® in the Treatment of Multiple Sclerosis (MU-90203)
Krejcová H.

Beta amyloid protein and plant cysteine proteinases influence the (3H)hemicholinium-3 binding site in vitro in rat hippocampus
Krištofiková Z., Klaschka J.

Evaluation of perspective agents for Alzheimer disease therapy by means of in vitro test with beta amyloid protein
Krištofiková Z., Klaschka J., Majer E., Fales E.

Plant cysteine proteases - new supportive agents in Alzheimer disease therapy?
Kristofikova Z., Stastny F.

Amyloid beta peptide 1-40 influences a recognition site of hemicholinium-3 sensitive choline carriers and their proteolytic degradation
Krištofiková Z., Tejkalová H.

Use of oral enzymes in multiple sclerosis patients
Mertin J., Stauder G., ESEMS working group

Proteases in the control and modulation of immunity
Nouza K., Olejár T., Nouza M.

Systemic administration of papain enhances proteolytic activity in some regions of excitotoxin-damaged rat brain
Pliss L., Lisy V., Kristofikova Z., Stastny F.

Use of oral enzymes in multiple sclerosis- phenotyping of peripheral blood lymphocytes from MS patients under long-term treatment with orally administered hydrolytic enzymes
Stauder G., Donnerstag B., Baumhackl U., Buschmans E.

Prevention of Murine EAE by Oral Hydrolytic Enzyme Treatment
Targoni O.S., Tary-Lehmann M., Lehmann P.V.

Systemic enzyme therapy, basic theoretical aspects, clinical application experience.
Veremeenko K.N., Kovalenko V.N.

Protease-activated receptors in inflammation, neuronal signaling and pain
Vergnolle N., Wallace J.L., Bunnett N.W.** and Hollenberg M.D.*  

Systemic Enzyme Therapy - Newest Status and Progress
Wrba H.

 


Inhalt - Neurologie german.jpg (1657 bytes)


Enzymtherapie bei Patienten mit Multipler Sklerose (MU-89201)
Baumhackl U.

Immunkomplexerkrankungen- Pathogenese und Therapie
Inderst R., Streichhan P., van Schaik W., Ransberger K.

Wobenzym® und Wobe-Mugos® zur Behandlung von Multipler Sklerose (MU-90203)
Krejcová H.

Grundlagen der Behandlung immunkomplexbedingter Erkrankungen mit Enzymen
Steffen C.

Enzymabbau von Immunkomplexen
Steffen C., Menzel J.

Systemische Enzymtherapie - Aktueller Stand und Fortschritte
Wrba H.


Materials available only in Russian   russia.jpg (3828 bytes)